55788.pdf
The poor clinical translation of oncological nanomedicine products is one of the greatest challenges faced by research today. The use of reductionist in vitro models of human cancer and non-predictive animal models is generally considered as one of the main causes of such very low translation rate....
| Language: | English |
|---|---|
| Published: |
InTechOpen
2021
|
